BRIEF published on 04/07/2026 at 18:05, 4 months ago Oxurion reporte son Assemblée Générale Annuelle Assemblée Générale Report Actifs Numériques Pharmaceutique Oxurion
PRESS RELEASE published on 04/07/2026 at 18:00, 4 months ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
PRESS RELEASE published on 04/07/2026 at 18:00, 4 months ago Uitstel Gewone Algemene Vergadering Oxurion NV kondigt uitstel van de Jaarlijkse Vergadering van Aandeelhouders aan vanwege niet gefinaliseerde jaarrekening. Het bedrijf specialiseert zich in farmaceutische onderaannemers. Gevestigd in Leuven, België Oxurion NV Leuven Uitstel Jaarlijkse Vergadering Farmaceutisch
BRIEF published on 03/19/2026 at 18:35, 4 months 19 days ago Oxurion projette l'acquisition d'une CRO internationale Acquisition Stratégie De Croissance Développement Clinique Oxurion CRO Internationale
BRIEF published on 03/19/2026 at 18:35, 4 months 19 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
BRIEF published on 03/19/2026 at 18:35, 4 months 19 days ago Oxurion annonce son intention d'acquérir une CRO internationale Acquisition Expansion Internationale Recherche Clinique Pharmaceutique Oxurion
BRIEF published on 03/19/2026 at 18:35, 4 months 19 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 4 months 19 days ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
PRESS RELEASE published on 03/19/2026 at 18:30, 4 months 19 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 4 months 19 days ago Oxurion signe une lettre d'intention pour l'acquisition d'une CRO internationale Oxurion NV annonce l'acquisition potentielle d'une CRO internationale opérant en Europe, en Afrique du Nord et au Moyen-Orient pour renforcer son modèle dédié au développement clinique Stratégie Acquisition Développement Clinique Oxurion NV CRO Internationale
Published on 08/07/2026 at 23:15, 18 hours 2 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 18 hours 17 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 18 hours 47 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 19 hours 2 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 52 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 17 hours 56 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 21 hours 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 22 hours 2 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 23 hours 7 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 22 hours 23 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 22 hours 23 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 22 hours 37 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 22 hours 37 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 23 hours 17 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
